Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
THE WOODLANDS, Texas, July 28 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported fin...
Alexza to Announce 2009 Second Quarter Financial Results and Update Its Clinical Pipeline Status on Wednesday, August 5, 2009
MOUNTAIN VIEW, Calif., July 27 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that it will release results for its second fiscal quarter ended June 30, 2009, on Wednesday, August 5, 2009, following the close of the U.S. financial market...
JNCI news brief: Improving the biomarker pipeline for early cancer detection
Several statistical and biological issues need to be addressed in order to improve biomarker identification for early detection of cancer, according to a commentary published online July 2 in the Journal of the National Cancer Institute .
The biomarker pipeline
to develop and evaluate cancer s...
Johnson & Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs
Early stage compounds and new filings targeted in five therapeutic areas
Expanding indications for strong core products builds "pipeline in a product"
Leveraging global capabilities and reach drives growth efforts in emerging markets
Biomarkers and diagnostics combine with therapi...
Strativa Pharmaceuticals Provides Product Pipeline Update
Files NDA for Ondansetron Orally Dissolving Film Strip
BioAlliance to Resubmit Loramyc(R) NDA
WOODCLIFF LAKE, N.J., April 9 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: P...
Medarex Highlights Oncology Pipeline at Needham Cancer Therapeutics Conference in New York City
PRINCETON, N.J., March 26 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) today announced that Dr. Geoffrey M. Nichol, Senior Vice President of Product Development at Medarex presented highlights from key programs in Medarex's oncology portfolio at the Needham & Company Cancer Therap...
Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status
Conference Call Scheduled for Today - Tuesday, March 10, 2009 at 4:30 p.m. Eastern Time
MOUNTAIN VIEW, Calif., March 10 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) reported today financial results for the fourth quarter and year ended December 31, 2008, and provid...
Blue Highway Selects Invention Machine Goldfire to Fuel Product Pipeline and Sustain Breakthrough Innovation
BOSTON, March 10 /PRNewswire/ -- Invention Machine , a leading provider of innovation software, today announced that it has been selected by Blue Highway LLC to help transform ideas into commercial products that will drive radical innovation in medical diagnostics. A Welch Allyn company, Blue...
Alexza to Announce 2008 Financial Results and Update Its Clinical Pipeline on Tuesday, March 10, 2009
MOUNTAIN VIEW, Calif., March 6 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that it will release results for its fiscal year ended December 31, 2008, on Tuesday, March 10, 2009, following the close of the U.S. financial markets. The Company will host an...
Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009
SHENZHEN, China, Jan. 16 /PRNewswire-Asia-FirstCall/ -- Mindray Medical
International Limited (NYSE: MR ), a leading developer, manufacturer and
marketer of medical devices worldwide, today announced updates on new product
launches and its product pipeline
for domestic and international marke...
Alexza to Announce 2008 Third Quarter Financial Results and Update Its Clinical Pipeline on Thursday, November 6, 2008
MOUNTAIN VIEW, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Alexza
Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that it will release
results for its third fiscal quarter ended September 30, 2008, on Thursday,
November 6, 2008, following the close of the U.S. financial markets. The
InNexus Biotechnology Announces Third Antibody and Expands Pipeline of Anticancer Compounds
BRITISH COLUMBIA, Canada, Aug. 6 /PRNewswire-FirstCall/ -- InNexus
Biotechnology Inc., (TSX VENTURE: IXS.V; OTC Bulletin Board: IXSBF)
( http://www.ixsbio.com ), a drug development company commercializing the
next generation of monoclonal antibodies based on its Dynamic Cross Linking
Halozyme Therapeutics to Hold Pipeline Update Conference Call on August 8
SAN DIEGO, July 31 /PRNewswire-FirstCall/ -- Halozyme Therapeutics,
Inc. (Nasdaq: HALO ), a biopharmaceutical company developing and
commercializing products targeting the extracellular matrix, today
announced that it will release financial results for the three and six
months ended June 30, ...
Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation
- Product Sales of $90 Million to $120 Million Expected in 2008
- Initial Results from JZP-6 Phase III Clinical Trial Expected by Year End
- New Data Provided on Pipeline
and Early-Stage Development Portfolio - 2008 Financial Guidance Provided
PALO ALTO, Calif., March...
Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy
- Company Projects Seven Products to Reach Sales of $1 Billion or More in 2008
- Late-Stage Pipeline
Offers Promising Outlook; 6 Launches Expected by end of 2011
- R&D Investment and Productivity Gains plus Aggressive Deal-Making R...
S*BIO Expands Pipeline With the Development of a Unique Flt3 -CDK Inhibitor as a Targeted Therapy for Acute Leukemias
SINGAPORE, Nov. 27 /PRNewswire/ -- S*BIO Pte Ltd today announced the
expansion of its proprietary pipeline, with its third development
candidate, SB1317. This is a novel orally-available small molecule compound
targeted for the treatment of acute leukemias.
SB1317 is designed to selectively ...
Biotech Company Builder Papadopoulos Says Investment in Innovation Needed to Advance Drug Pipeline at Massachusetts Biotechnology Council's Ninth Annual MASS Opportunities Investment Conference
Governor Patrick Asks Biotech Community for Continued Efforts on $1 Billion Life Sciences Legislation Future of Biotechnology Featured: RNA, Nanomedicine, Mitochondria Capital Financing for Biotech Sector Could Hit New Highs for 2007 Editor's Note: Reporters can listeni...
SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference
DUBLIN, Calif., Oct. 17 /PRNewswire-FirstCall/ -- SuperGen Inc.
(Nasdaq: SUPG ), a pharmaceutical company dedicated to the discovery, rapid
development and commercialization of therapies for solid tumors and
hematological malignancies, today announced that multiple abstracts have
ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments
- ISTA acquires exclusive North American rights to bepotastine for nasal allergy -
IRVINE, Calif., Sept. 26 /PRNewswire-FirstCall/ -- ISTA
Pharmaceuticals, Inc. (Nasdaq: ISTA ), announced today it has licensed
exclusive North American rights to nasal dosage forms...
Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
~ Presentations Include 1 Oral Session and 21 Poster Sessions ~ ~ Replidyne Debuts New Clostridium difficile Program ~
LOUISVILLE, Colo., Sept. 17 /PRNewswire-FirstCall/ -- Replidyne, Inc.
(Nasdaq: RDYN ) announced today that it will be presenting 21 posters
highlighting three maj...
Ovation further advances development pipeline with new phase III epilepsy study
DEERFIELD, Ill., September 4, 2007 OVATION Pharmaceuticals, Inc. announced the initiation of a pivotal Phase III clinical trial evaluating clobazam, a unique 1,5 benzodiazapine with significant anticonvulsant properties, as adjunctive treatment for patients with Lennox-Gastaut syndrome (LGS), one...
CPC Strengthens Foundation as a Closure Products Company with its Vertically Integrated Product Pipeline
LAS VEGAS, June 9 /PRNewswire-FirstCall/ -- CPC of America, Inc. (OTC Bulletin Board: CPCF), announced today that its first patent filing of a synthetic sealant for its specific application to the MedClose(TM) Vascular Closure System (VCS) -- previously announced May 21, 2009 -- represents a much ...
Michael J. Fox Foundation Announces $2 Million Funding Commitment to Drive Development of Parkinson's Disease Biomarker Pipeline
Initiative is one element of broader strategy to speed biomarkers progress
NEW YORK, May 7 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research announced a funding commitment of $2 million for Biomarkers 2009 . This fourth round of biomarker funding by MJFF ai...
Cancer drugs in the pipeline
SAN ANTONIO - Scientists in the clinic and the laboratory continue to work to drive breast cancer mortality rates down with breakthrough drugs. With tamoxifen's discovery 30 years behind us, and the impact of Herceptin still being felt, researchers are studying zoledronic acid, aromatase inhibitor...
InfaCare Pharmaceutical Corporation Raises $28 Million in Series B Financing to Advance Its Neonatal Pipeline
TREVOSE, Pa., Oct. 27 /PRNewswire/ -- InfaCare Pharmaceutical
Corporation, a late stage specialty pharmaceutical company focused on the
development of products to treat neonatal diseases, today announced a $28
million private placement of its Series B Preferred Stock. New investor,
The Scientific Business of Thomson Reuters Publishes Pharma Matters - a Series of Reviews Covering Various Aspects of the Pharmaceutical Pipeline
Quarterly Reports Utilize Strategic Intelligence and Competitive Analysis
from Thomson Reuters to Analyze Promising Drugs Changing Clinical Phase,
Leading Sources of Information on Medical Research and the U.S. Generics Market
LONDON and PHILADELPHIA, June 4 ...
Pfizer Partners with REvolution Computing to Improve Medicine Production Pipeline
Parallel caret 'R' Software Provides Faster Analysis of Safety Characteristics of New Drugs
BOSTON, April 29 /PRNewswire/ -- BIO IT World Conference and Exposition
-- REvolution Computing, the leading provider of commercial open-source "R"
software for computational s...
CJPS Enterprises to Expand Efforts of 21st Century Jobs Fund Life Sciences Pipeline
BLOOMFIELD HILLS, Mich., March 26 /PRNewswire/ -- The next phase of
Michigan's initiative to grow its life sciences industry will be lead by
CJPS Enterprises, LLC (http://www.CJPS-Enterprises.com ). CJPS Enterprises was
assigned by the Michigan Economic Development Corporation to create a
GlaxoSmithKline Presents Innovative Neuroscience Pipeline
PHILADELPHIA and LONDON, Dec. 13 /PRNewswire-FirstCall/ --
GlaxoSmithKline (GSK) plc today presented an overview of its neuroscience
portfolio and the company's disease area strategy to investors and analysts
at a meeting in New York.
Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline
Novartis Leads the Drug List With its Alzheimer's Disease Treatment Exelon TDS
PHILADELPHIA, Nov. 30 /PRNewswire-FirstCall/ -- Thomson Scientific,
part of The Thomson Corporation (NYSE: TOC ; TSX: TOC) and leading provider
of information solutions to the worldw...
China Holdings, Inc. Announces Its 3rd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 150 MW in Biomass Energy Pipeline
LAS VEGAS, Nov. 20 /Xinhua-PRNewswire-FirstCall/ -- China Holdings,
Inc., a global diversified asset holdings company, and its subsidiaries
engage in multiple China-focused business activities including energy,
renewable energy, resources, utilities, finance, real estate, and
Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline
Von Hoff details CTI's new cancer drug development platform
SEATTLE, Nov. 14 /PRNewswire-FirstCall/ -- Analysts, fund managers, and
investors heard first-hand the progress and prospects of three of Cell
Therapeutics, Inc.'s (CTI) (Nasdaq: CTIC and MTAX: CTIC) oncology drug
China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline
LAS VEGAS, Nov. 5 /Xinhua-PRNewswire-FirstCall/ -- China Holdings, Inc.
(OTC Bulletin Board: CHHL), a global diversified asset holdings Company,
and its subsidiaries engage in multiple China-focused business activities
including energy, renewable energy, resources, utilities, finance, real
Sanofi-Aventis renews licenses for Genomatix chip analysis pipeline
Genomatix Software GmbH (Munich) announced today that Sanofi-Aventis has renewed its licenses for Multi-Site access to the Genomatix Microarray Analysis Pipeline.
provides a fully integrated, user friendly solution for the analysis of expression and tiling microarray experiments, inc...
New Treatment Option in the Pipeline for Those Suffering From Lung Cancers
According to the medical physicist Cihat Ozhasoglu, Ph.D. of the University of Pittsburgh Medical Center a highly intense beam of radiation that is delivered// by a robotic arm is very effective in the complete removal of lung tumors in some patients.
Patients with lung tumors are the worst aff...
$30 M Aid in the pipeline by WB for bird flu in Turkey
Taking into consideration the epidemic that is bird flu which is taking the world by storm WB might grant $30 M in aid to Turkey.//
This follows a high level and numerous evaluations by the World Bank.
But all this bore fruit and according to latest reports World Bank (WB) concluded Turkey mi...
AEterna's acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
AEterna Laboratories Inc., a biopharmaceutical company focused on the development of novel therapeutic treatments in oncology and endocrinology recently acquired the new German based biopharmaceutical company, Zentaris AG. Following this acquisition// the new entity has in the pipeline
A Novel Vaccine to Combat Bird Flu in the Pipeline
The novel vaccine that is being formulated by scientists, promises protection against all strains of flu virus. It is expected to be efficient to fight 24 strains// of influenza A virus, that is the cause of outbreaks of both bird flu and winter flu.
Two injections of this vaccine is expected ...
Miracle Cancer Drug in the Pipeline
Cure for cancer has been on the wish-list of many scientists and sufferers the world over. Now, a world of promise awaits the brain–child of an //Australian scientist, whose perseverance on the capacity of a drug to thwart the growth of cancer cells, seems to have paid off.
Professor Chris P...
Gene Therapy Technique for Inherited Heart Problems in The Pipeline
According to the researchers at the University of Florida, Gainesville, mice based experiments were found to be successful in delivering genes to treat hereditary diseases of the heart.//
This new technique was found to be successful in mice affected with muscular dystrophy that damages the he...